Prospective randomized controlled trial investigating the type of sutures used during hepatectomy

Table 2 Comparison of clinicopathological data of the groups

Variables	SSI(+)	SSI(-)	P-value
	(n = 17)	(n = 108)
Age	68 ± 10	67 ± 11	0.667
Male/female	13 /4	65/43	0.287
Body mass index	24.3 ± 5.2	23.0 ± 3.9	0.208
Diabetes mellitus (%)	35.3	25.0	0.384
HBV (%)	23.5	18.5	0.703
HCV (%)	64.7	41.7	0.560
Albumin (g/dL)	3.6 ± 0.4	3.6 ± 0.5	0.977
Total bilirubin (mg/dL)	0.7 ± 0.3	0.7 ± 0.4	0.938
AST (IU/L)	56 ± 22	43 ± 29	0.070
Platelet count (x 104/μL)	20.7 ± 7.3	20.4 ± 11.0	0.904
ICGR15 (%)	19.9 ± 8.3	15.3 ± 10.7	0.101
Child-Pugh A/B	17/0	100/8	0.597
HCC/non-HCC	15/2	78/30	0.638
Liver cirrhosis (ch/lf/lc)	2/7/8	28/35/45	0.435
Anatomical/nonanatomical	8/9	32/76	0.228
Operation time
> 265 min (%)	76.5	44.4	< 0.050
Blood loss
> 1000 g (%)	41.2	18.5	< 0.050
Transfusion (%)	11.8	15.7	0.999
Bile leakage (%)	35.3	0	< 0.010
Vicryl/silk	7/10	55/53	0.603
Hospital stay (d)	29 ± 23	15 ± 12	< 0.010

SSI: Surgical site infection; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; AST: Aspartate aminotransferase.